专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2008002604A3 QOS-AWARE SERVICE FLOW MAPPING IN MOBILE WIRELESS ALL IP NETWORKS 审中-公开
公开(公告)号：WO2008002604A3
公开(公告)日：2008-01-03
申请号：PCT/US2007/014899
申请日：2007-06-26
申请人： CISCO TECHNOLOGY, INC. , YEGANI, Parviz , OSWAL, Anand, K. , STAMMERS, Timothy, P.
发明人： YEGANI, Parviz , OSWAL, Anand, K. , STAMMERS, Timothy, P.
IPC分类号： H04Q7/00
摘要： In one embodiment, techniques provide QoS-aware service flow mapping in an access network. A message is received from an access device at a gateway in the access network. The message includes a traffic flow specification. The traffic flow specification may include packet filter information, which is used to install a packet filter to route traffic to the access device. The gateway creates a session and associates the packet filter with it. When an incoming packet is received at the network device, the packet is matched to the packet filter. The incoming packet is then sent to the access device for the session. The traffic flow specification may also specify QoS parameters that are desired. The QoS parameters may then be applied to the packet sent to the access device. The gateway and access device may negotiate to determine a QoS to apply.

2. 发明申请

WO2007103481A2 ESTABLISHING FACETS OF A POLICY FOR A COMMUNICATION SESSION 审中-公开
标题翻译：建立通信会议政策的要素
公开(公告)号：WO2007103481A2
公开(公告)日：2007-09-13
申请号：PCT/US2007/005900
申请日：2007-03-06
申请人： CISCO TECHNOLOGY, INC. , ROSENBERG, Jonathan, D. , ANDREASEN, Flemming, S. , STAMMERS, Timothy, P.
发明人： ROSENBERG, Jonathan, D. , ANDREASEN, Flemming, S. , STAMMERS, Timothy, P.
IPC分类号： H04K1/00
CPC分类号： H04W12/08 , G06Q20/102 , H04L12/14 , H04L12/1403 , H04L41/0893 , H04L41/5029 , H04L41/5061 , H04L45/50 , H04L47/10 , H04L47/14 , H04L47/15 , H04L47/70 , H04L47/724 , H04L47/805 , H04L47/824 , H04L61/2015 , H04L63/08 , H04L63/0892 , H04L63/102 , H04L63/162 , H04L65/1006 , H04L65/1016 , H04L67/141 , H04L69/14 , H04L69/24 , H04W8/26 , H04W12/06 , H04W28/18 , H04W36/0033 , H04W36/12 , H04W36/14 , H04W48/14 , H04W60/00 , H04W80/04 , H04W80/10 , H04W92/02
摘要： Establishing one or more facets of a policy includes facilitating a communication session for an access terminal at a visited network. The access terminal is associated with a home network having a home policy server. The policy is received at a visited policy server of the visited network. The policy comprises the facets. If the facets are unacceptable, the facets are negotiated until a stopping point is reached. The negotiation includes adjusting by the visited policy server at least one facet of the one or more facets, and notifying the home policy server of the adjustment. The facets are established in accordance with the negotiation.
摘要翻译：建立策略的一个或多个方面包括促进访问网络处的接入终端的通信会话。接入终端与具有归属策略服务器的归属网络相关联。在受访网络的访问策略服务器上收到该策略。政策包括方面。如果这些方面是不可接受的，则会协商方面，直到达到停止点。协商包括由访问策略服务器调整一个或多个方面的至少一个方面，并通知归属策略服务器调整。方面是按照谈判建立的。

3. 发明申请

WO2007098165A3 OPTIMAL HOME AGENT ALLOCATION 审中-公开
公开(公告)号：WO2007098165A3
公开(公告)日：2007-08-30
申请号：PCT/US2007/004415
申请日：2007-02-20
申请人： CISCO TECHNOLOGY, INC. , YEGANI, Parviz , STAMMERS, Timothy , IYER, Jayaraman , OSWAL, Anand K.
发明人： YEGANI, Parviz , STAMMERS, Timothy , IYER, Jayaraman , OSWAL, Anand K.
IPC分类号： H04Q7/20
摘要： Particular embodiments provide an optimal allocation of a bearer manager or home agent. In one embodiment, a message is received from a mobile node requesting access to a visiting network that is different from a home network for the mobile node. An authentication request is sent to the home network requesting authentication for access. The authentication request indicates that a home agent has not been assigned. The home AAA server then sends a response that indicates the visiting AAA server can assign a home agent for the mobile node. The visiting AAA server then assigns a home agent that is optimally determined. The visiting home agent is different from a home agent that is found in the mobile node's home network. When a registration request is received, an IP gateway may send the registration request to the visiting home agent, which may not be sent back to the home network.

4. 发明申请

WO2007098165A2 OPTIMAL HOME AGENT ALLOCATION 审中-公开
标题翻译：最佳家庭代理分配
公开(公告)号：WO2007098165A2
公开(公告)日：2007-08-30
申请号：PCT/US2007004415
申请日：2007-02-20
申请人： CISCO TECH INC , YEGANI PARVIZ , STAMMERS TIMOTHY , IYER JAYARAMAN , OSWAL ANAND K
发明人： YEGANI PARVIZ , STAMMERS TIMOTHY , IYER JAYARAMAN , OSWAL ANAND K
IPC分类号： H04W8/06 , H04W12/06 , H04W80/04
CPC分类号： H04W8/065 , H04L63/08 , H04L63/0892 , H04W12/06 , H04W80/04
摘要： Particular embodiments provide an optimal allocation of a bearer manager or home agent. In one embodiment, a message is received from a mobile node requesting access to a visiting network that is different from a home network for the mobile node. An authentication request is sent to the home network requesting authentication for access. The authentication request indicates that a home agent has not been assigned. The home AAA server then sends a response that indicates the visiting AAA server can assign a home agent for the mobile node. The visiting AAA server then assigns a home agent that is optimally determined. The visiting home agent is different from a home agent that is found in the mobile node's home network. When a registration request is received, an IP gateway may send the registration request to the visiting home agent, which may not be sent back to the home network.
摘要翻译：特定实施例提供承载管理器或归属代理的最佳分配。在一个实施例中，从移动节点接收请求访问不同于移动节点的归属网络的访问网络的消息。认证请求被发送到家庭网络，请求认证进行访问。认证请求表示没有分配归属代理。然后，归属AAA服务器发送响应，其指示访问AAA服务器可以为移动节点分配归属代理。然后，访问的AAA服务器分配最佳确定的归属代理。访问归属代理与在移动节点的家庭网络中找到的归属代理不同。当接收到注册请求时，IP网关可以将该注册请求发送到访问归属代理，该归属代理可能不被发送回家庭网络。

5. 发明申请

WO2011032277A1 QUINAZOLINONE DERIVATIVES AS VIRAL POLYMERASE INHIBITORS 审中-公开
标题翻译：喹唑啉酮衍生物作为病毒聚合酶抑制剂
公开(公告)号：WO2011032277A1
公开(公告)日：2011-03-24
申请号：PCT/CA2010/001443
申请日：2010-09-16
申请人： BOEHRINGER INGELHEIM INTERNATIONAL GmbH , STAMMERS, Timothy , BARBEAU, Xavier , BEAULIEU, Pierre , BERTRAND-LAPERLE, Megan , BROCHU, Christian , EDWARDS, Paul, J. , FORGIONE, Pasquale , GODBOUT, Cédrickx , HUCKE, Oliver , JOLY, Marc-André , LANDRY, Serge , LEPAGE, Olivier , NAUD, Julie , PESANT, Marc , POIRIER, Martin , POIRIER, Maude , THAVONEKHAM, Bounkham
发明人： STAMMERS, Timothy , BARBEAU, Xavier , BEAULIEU, Pierre , BERTRAND-LAPERLE, Megan , BROCHU, Christian , EDWARDS, Paul, J. , FORGIONE, Pasquale , GODBOUT, Cédrickx , HUCKE, Oliver , JOLY, Marc-André , LANDRY, Serge , LEPAGE, Olivier , NAUD, Julie , PESANT, Marc , POIRIER, Martin , POIRIER, Maude , THAVONEKHAM, Bounkham
IPC分类号： C07D401/12 , A61K31/517 , A61K31/14 , C07C211/29 , C07C233/13 , C07C237/44 , C07C251/48 , C07C255/58 , C07D213/74 , C07D239/42 , C07D239/88 , C07D401/14 , C07D403/12 , C07D409/14 , C07D413/12 , C07F5/02
CPC分类号： C07D401/12 , A61K31/14 , A61K31/517 , C07C211/29 , C07C233/11 , C07C237/44 , C07C251/48 , C07C255/58 , C07C255/59 , C07D401/14 , C07D403/12 , C07D409/14 , C07D413/12 , C07F5/025
摘要： Compounds of formula I: (I) wherein X, R 2 , R 3 , R 5 and R 6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
摘要翻译：式I化合物（其中X，R 2，R 3，R 5和R 6在本文中定义）可用作丙型肝炎病毒NS5B聚合酶的抑制剂。

6. 发明申请

WO2007103504A3 ACCESS TERMINAL FOR COMMUNICATING PACKETS USING A HOME ANCHORED BEARER PATH OR A VISITED ANCHORED BEARER PATH 审中-公开
标题翻译：用于通过家用锚固路径或可视化锚固路径来通信分组的接入终端
公开(公告)号：WO2007103504A3
公开(公告)日：2007-12-21
申请号：PCT/US2007005937
申请日：2007-03-06
申请人： CISCO TECH INC , IYER JAYARAMAN R , LEUNG KENT K , STAMMERS TIMOTHY P , OSWAL ANAND K
发明人： IYER JAYARAMAN R , LEUNG KENT K , STAMMERS TIMOTHY P , OSWAL ANAND K
IPC分类号： H04W8/26 , H04W12/08 , H04W28/18 , H04W36/00 , H04W36/12 , H04W36/14 , H04W48/14 , H04W60/00 , H04W80/04 , H04W80/10 , H04W92/02
CPC分类号： H04W12/08 , G06Q20/102 , H04L12/14 , H04L12/1403 , H04L41/0893 , H04L41/5029 , H04L41/5061 , H04L45/50 , H04L47/10 , H04L47/14 , H04L47/15 , H04L47/70 , H04L47/724 , H04L47/805 , H04L47/824 , H04L61/2015 , H04L63/08 , H04L63/0892 , H04L63/102 , H04L63/162 , H04L65/1006 , H04L65/1016 , H04L67/141 , H04L69/14 , H04L69/24 , H04W8/26 , H04W12/06 , H04W28/18 , H04W36/0033 , H04W36/12 , H04W36/14 , H04W48/14 , H04W60/00 , H04W80/04 , H04W80/10 , H04W92/02
摘要： Communicating packets along a bearer path includes receiving a home network address and a visited network address at an access terminal. The home network address corresponds to a home anchored bearer path anchored at a home network of the access terminal. The visited network address corresponds to a visited anchored bearer path anchored at a visited network. The access terminal determines whether to use the home anchored bearer path or the visited anchored bearer path, and communicates packets using the home network address or the visited network address in accordance with the determination.
摘要翻译：沿承载路径通信数据包包括在接入终端接收归属网络地址和被访问网络地址。归属网络地址对应于锚定在接入终端的归属网络上的归属锚定承载路径。所访问的网络地址对应于在访问网络上锚定的访问锚定承载路径。接入终端确定是否使用归属承载路径或访问锚定承载路径，并且根据该确定使用家庭网络地址或访问网络地址来传送分组。

7. 发明申请

WO2005080388A1 VIRAL POLYMERASE INHIBITORS 审中-公开
标题翻译：病毒聚合酶抑制剂
公开(公告)号：WO2005080388A1
公开(公告)日：2005-09-01
申请号：PCT/CA2005/000208
申请日：2005-02-18
申请人： BOEHRINGER INGELHEIM INTERNATIONAL GmbH , BOEHRINGER INGELHEIM PHARMA GmbH & CO KG , TSANTRIZOS, Youla, S. , CHABOT, Catherine , BEAULIEU, Pierre , BROCHU, Christian , POIRIER, Martin , STAMMERS, Timothy, A. , THAVONEKHAM, Bounkham , RANCOURT, Jean
发明人： TSANTRIZOS, Youla, S. , CHABOT, Catherine , BEAULIEU, Pierre , BROCHU, Christian , POIRIER, Martin , STAMMERS, Timothy, A. , THAVONEKHAM, Bounkham , RANCOURT, Jean
IPC分类号： C07D417/14
CPC分类号： C07D487/04 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04
摘要： An enantiomer, diastereoisomer or tautomer of a compound, represented by formula (I): wherein either A or B is nitrogen and the other B or A is C, and the radicals R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 are as defined herein, or a salt or ester thereof as viral polymerase inhibitors. The compound is used as an inhibitor of RNA dependent RNA polymerases, particularly those viral polymerases within the Flaviviridae family, more particularly to HCV polymerase.
摘要翻译：由式（I）表示的化合物的对映体，非对映异构体或互变异构体：其中A或B为氮，另一个B或A为C，基团R 1，R 2，R 3， R 4，R 5，R 6，R 7，R 8，R 9和R 10如本文所定义，或其盐或酯作为病毒聚合酶抑制剂。该化合物用作RNA依赖性RNA聚合酶的抑制剂，特别是黄病毒科中的那些病毒聚合酶，更特别地涉及HCV聚合酶。

8. 发明申请

WO0047551A3 INHIBITORS OF ASPARTYL PROTEASE 审中-公开
标题翻译： ASPARTYL PROTEASE的抑制剂
公开(公告)号：WO0047551A3
公开(公告)日：2001-08-16
申请号：PCT/US0003288
申请日：2000-02-09
申请人： VERTEX PHARMA , HALE MICHAEL R , BAKER CHRISTOPHER T , STAMMERS TIMOTHY A , SHERRILL RONALD G , SPALTENSTEIN ANDREW , FURFINE ERIC S , MALTAIS FRANCOIS , ANDREWS CLARENCE WEBSTER III , MILLER JOHN F , SAMANO VICENTE
发明人： HALE MICHAEL R , BAKER CHRISTOPHER T , STAMMERS TIMOTHY A , SHERRILL RONALD G , SPALTENSTEIN ANDREW , FURFINE ERIC S , MALTAIS FRANCOIS , ANDREWS CLARENCE WEBSTER III , MILLER JOHN F , SAMANO VICENTE
IPC分类号： C07D317/28 , A61K9/20 , A61K9/48 , A61K31/27 , A61K31/275 , A61K31/34 , A61K31/341 , A61K31/357 , A61K31/36 , A61K31/5377 , A61K31/662 , A61P31/14 , A61P31/18 , A61P43/00 , C07B53/00 , C07C271/20 , C07C271/22 , C07C311/19 , C07C311/29 , C07C311/42 , C07C311/46 , C07C317/18 , C07D307/20 , C07D317/62 , C07D319/06 , C07D409/12 , C07D493/04 , C07F9/6561 , A61K31/18 , A61K31/665 , C07D407/12
CPC分类号： C07D493/04 , C07C311/19 , C07C311/29 , C07C311/42 , C07C311/46 , C07C317/18 , C07C2601/08 , C07C2601/14 , C07D307/20 , C07D317/14 , C07D319/06 , C07D319/18 , C07D407/12 , C07F9/6561
摘要： The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also relates to methods for inhibiting the activity of HIV aspartyl protease using the compounds of this invention and methods for screening compounds for anti-HIV activity.
摘要翻译：本发明涉及一类新型的磺酰胺，它们是天冬氨酰蛋白酶抑制剂。在一个实施方案中，本发明涉及以特定结构和物理化学特征为特征的新型HIV天冬氨酰蛋白酶抑制剂。本发明还涉及包含这些化合物的药物组合物。本发明的化合物和药物组合物特别适用于抑制HIV-1和HIV-2蛋白酶活性，因此可有利地用作针对HIV-1和HIV-2病毒的抗病毒剂。本发明还涉及使用本发明化合物抑制HIV天冬氨酰蛋白酶的活性的方法和用于筛选抗HIV活性化合物的方法。

9. 发明申请

WO2007103481A3 ESTABLISHING FACETS OF A POLICY FOR A COMMUNICATION SESSION 审中-公开
标题翻译：建立通信会议政策的要素
公开(公告)号：WO2007103481A3
公开(公告)日：2008-04-03
申请号：PCT/US2007005900
申请日：2007-03-06
申请人： CISCO TECH INC , ROSENBERG JONATHAN D , ANDREASEN FLEMMING S , STAMMERS TIMOTHY P
发明人： ROSENBERG JONATHAN D , ANDREASEN FLEMMING S , STAMMERS TIMOTHY P
IPC分类号： G06F15/16 , G06F15/173 , G06F15/177 , H04L9/00 , H04W8/26 , H04W12/08 , H04W28/18 , H04W36/00 , H04W36/12 , H04W36/14 , H04W48/14 , H04W60/00 , H04W80/04 , H04W80/10 , H04W92/02
CPC分类号： H04W12/08 , G06Q20/102 , H04L12/14 , H04L12/1403 , H04L41/0893 , H04L41/5029 , H04L41/5061 , H04L45/50 , H04L47/10 , H04L47/14 , H04L47/15 , H04L47/70 , H04L47/724 , H04L47/805 , H04L47/824 , H04L61/2015 , H04L63/08 , H04L63/0892 , H04L63/102 , H04L63/162 , H04L65/1006 , H04L65/1016 , H04L67/141 , H04L69/14 , H04L69/24 , H04W8/26 , H04W12/06 , H04W28/18 , H04W36/0033 , H04W36/12 , H04W36/14 , H04W48/14 , H04W60/00 , H04W80/04 , H04W80/10 , H04W92/02
摘要： Establishing one or more facets of a policy includes facilitating a communication session for an access terminal at a visited network. The access terminal is associated with a home network having a home policy server. The policy is received at a visited policy server of the visited network. The policy comprises the facets. If the facets are unacceptable, the facets are negotiated until a stopping point is reached. The negotiation includes adjusting by the visited policy server at least one facet of the one or more facets, and notifying the home policy server of the adjustment. The facets are established in accordance with the negotiation.
摘要翻译：建立策略的一个或多个方面包括促进访问网络处的接入终端的通信会话。接入终端与具有归属策略服务器的归属网络相关联。在受访网络的访问策略服务器上收到该策略。政策包括方面。如果方面是不可接受的，则会协商方面，直到达到停止点。协商包括由访问策略服务器调整一个或多个方面的至少一个方面，并通知归属策略服务器调整。方面是根据谈判建立的。

10. 发明申请

WO2008019477A1 VIRAL POLYMERASE INHIBITORS 审中-公开
标题翻译：病毒聚合酶抑制剂
公开(公告)号：WO2008019477A1
公开(公告)日：2008-02-21
申请号：PCT/CA2007/001363
申请日：2007-08-06
申请人： BOEHRINGER INGELHEIM INTERNATIONAL GmbH , BOEHRINGER INGELHEIM PHARMA GMBH & CO KG , BEAULIEU, Pierre, L , COULOMBE, René , FAZAL, Gulrez , GOULET, Sylvie , POIRIER, Martin , RANCOURT, Jean , STAMMERS, Timothy , THAVONEKHAM, Bounkham
发明人： BEAULIEU, Pierre, L , COULOMBE, René , FAZAL, Gulrez , GOULET, Sylvie , POIRIER, Martin , RANCOURT, Jean , STAMMERS, Timothy , THAVONEKHAM, Bounkham
IPC分类号： C07D213/62 , A61K31/351 , A61K31/381 , A61K31/415 , A61K31/4184 , A61K31/44 , A61K31/4439 , A61K31/497 , A61K31/5377 , A61P31/14 , C07D231/18 , C07D235/12 , C07D309/12 , C07D333/32 , C07D401/06 , C07D401/12 , C07D413/04 , C07D413/06 , C07D417/06
CPC分类号： C07D213/68 , C07D213/70 , C07D213/71 , C07D213/73 , C07D213/74 , C07D213/79 , C07D213/80 , C07D213/85 , C07D213/89 , C07D215/227 , C07D217/24 , C07D231/18 , C07D235/08 , C07D235/12 , C07D237/14 , C07D239/34 , C07D239/56 , C07D241/20 , C07D241/24 , C07D307/20 , C07D309/12 , C07D333/32 , C07D401/04 , C07D401/06 , C07D401/12 , C07D405/12 , C07D413/06 , C07D413/12 , C07D417/06 , C07D417/12 , C07D471/04
摘要： Compounds of formula (I) : wherein X, R 2 , R 3 , R 5 and R 6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
摘要翻译：式（I）化合物：其中X，R 2，R 3，R 5和R 6是可用作丙型肝炎病毒NS5B聚合酶的抑制剂。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式